Topic:

April 2024

NATIONAL ADVISORY COMMITTEE OF IMMUNIZATION (NACI) RAPID RESPONSE: ADDITIONAL DOSE OF COVID-19 VACCINE IN IMMUNOCOMPROMISED INDIVIDUALS FOLLOWING 1- OR 2- DOSE PRIMARY SERIES

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Nuvaxovid in Canada: How to Access the COVID-19 Vaccine

Read

The Lupus Canada Annual General Meeting 2026

Read

Lupus Canada Impact Report 2025 | Advocacy, Awareness & Research Outcomes

Read